Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-03-22

FDA Approved: SIMLIYA — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved SIMLIYA, a generic combined oral contraceptive containing desogestrel and ethinyl estradiol, under an Original Application (ANDA 206853) by Aurobin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SIMLIYA (Desogestrel and Ethinyl Estradiol)

Snippet

ORIG AP for SIMLIYA (DESOGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL)